These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1593098)

  • 41. Glycopeptide resistance in enterococci.
    Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F
    Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vancomycin-resistant enterococci.
    Uttley AH; Woodford N; Johnson AP; Cookson B; George RC
    Lancet; 1993 Sep; 342(8871):615; author reply 616. PubMed ID: 8102741
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibiotic resistance. Nosocomial gram-positive infection.
    Cookson B; Morrison D; Marples R
    J Med Microbiol; 1997 Jun; 46(6):439-42. PubMed ID: 9379468
    [No Abstract]   [Full Text] [Related]  

  • 45. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
    Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
    J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin-resistant enterococci.
    Palmer SM; Rybak MJ
    Pharmacotherapy; 1996; 16(5):819-29. PubMed ID: 8888077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage.
    Torres C; Reguera JA; Sanmartin MJ; Pérez-Díaz JC; Baquero F
    J Antimicrob Chemother; 1994 Mar; 33(3):553-61. PubMed ID: 8040119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 2000 Nov; 38(3):177-9. PubMed ID: 11109018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Humphreys H; Keane CT
    Lancet; 1997 Sep; 350(9079):737-8. PubMed ID: 9291923
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibiotic resistance among clinically important gram-positive bacteria in the UK.
    Johnson AP
    J Hosp Infect; 1998 Sep; 40(1):17-26. PubMed ID: 9777517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of vancomycin resistance in Enterococcus durans.
    Cercenado E; Unal S; Eliopoulos CT; Rubin LG; Isenberg HD; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1995 Nov; 36(5):821-5. PubMed ID: 8626263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance in gram-positive bacteria: epidemiological aspects.
    Witte W
    J Antimicrob Chemother; 1999 Sep; 44 Suppl A():1-9. PubMed ID: 10511391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin resistance: decoding the molecular logic.
    Walsh CT
    Science; 1993 Jul; 261(5119):308-9. PubMed ID: 8392747
    [No Abstract]   [Full Text] [Related]  

  • 55. Vancomycin-dependent enterococci: curious phenomenon or serious threat?
    Stewart B; Hall L; Duke B; Ball D
    J Antimicrob Chemother; 1997 Nov; 40(5):734-5. PubMed ID: 9421327
    [No Abstract]   [Full Text] [Related]  

  • 56. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Emerging infectious and drug-resistant diseases--vancomycin resistant gram-positive cocci].
    Hanaki H; Hiramatsu K
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2075-80. PubMed ID: 9480313
    [No Abstract]   [Full Text] [Related]  

  • 60. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.